Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease

American Journal of Cardiology

Volumn 110, Issue 10, 2012, Pages 1440-1445

  Venkataraman, Rajesh ^a   Chen, Ji ^b   Garcia, Ernest V ^b   Belardinelli, Luiz ^c   Hage, Fadi G ^a   Heo, Jaekyeong ^a   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RANOLAZINE;

AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART LEFT VENTRICLE ASYNERGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART RATE; HUMAN; LEFT VENTRICULAR DYSSYNCHRONY; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ACETANILIDES; AGED; CORONARY ARTERY DISEASE; ENZYME INHIBITORS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HUMANS; MALE; PIPERAZINES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84868212488     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.06.055     Document Type: Article

References (21)

1. L. Belardinelli, J.C. Shryock, H. Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart 92 Suppl 4 2006 iv6 iv14
2. S.L. Hale, J.C. Shryock, L. Belardinelli, M. Sweeney, R.A. Kloner Late sodium current inhibition as a new cardioprotective approach J Mol Cell Cardiol 44 2008 954 967
3. P.H. Stone, N.A. Gratsiansky, A. Blokhin, I.Z. Huang, L. Meng ERICA Investigators Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial J Am Coll Cardiol 48 2006 566 575 (Pubitemid 44093970)
4. M.C. Allely, B.J. Alps Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion Br J Pharmacol 99 1990 5 6 (Pubitemid 20033773)
5. H. Fraser, L. Belardinelli, L. Wang, P.E. Light, J.J. McVeigh, A.S. Clanachan Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts J Mol Cell Cardiol 41 2006 1031 1038 (Pubitemid 44791334)
6. S.L. Hale, J.A. Leeka, R.A. Kloner Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel J Pharmacol Exp Ther 318 2006 418 423
7. R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, A.E. Iskandrian A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images J Am Coll Cardiol Imaging 2 2009 1301 1309
8. R. Venkataraman, W. Aljaroudi, L. Belardinelli, J. Heo, A.E. Iskandrian The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality J Nucl Cardiol 18 2011 456 462
9. A.E. Iskandrian, E.V. Garcia Nuclear Cardiac Imaging: Principles and Applications 4th ed. 2008 Oxford University Press Oxford
10. J. Chen, E.V. Garcia, R.D. Folks, C.D. Cooke, T.L. Faber, E.L. Tauxe, A.E. Iskandrian Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony J Nucl Cardiol 12 2005 687 695 (Pubitemid 43033609)
11. J. Chen, A.P. Kalogeropoulos, L. Verdes, J. Butler, E.V. Garcia Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF J Nucl Cardiol 18 2011 299 308
12. M.T. Maeder, D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
13. H. Matsumura, A. Hara, H. Hashizume, K. Maruyama, Y. Abiko Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate Jpn J Pharmacol 77 1998 31 39 (Pubitemid 28263988)
14. S. Sossalla, S. Wagner, E.C.L. Rasenack, H. Ruff, S.L. Weber, F.A. Schöndube, T. Tirilomis, G. Tenderich, G. Hasenfuss, L. Belardinelli, L.S. Maier Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation J Mol Cell Cardiol 45 2008 32 43
15. W. Hayashida, C. van Eyll, M.F. Rousseau, H. Pouleur Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease Cardiovasc Drugs Ther 8 1994 741 747 (Pubitemid 24376754)
16. D.A. Morrow, B.M. Scirica, M.S. Sabatine, J.A. de Lemos, S.A. Murphy, P. Jarolim, P. Theroux, C. Bode, E. Braunwald B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial J Am Coll Cardiol 55 2010 1189 1196
17. V.M. Figueredo, G.S. Pressman, A. Romero-Corral, E. Murdock, P. Holderbach, D.L. Morris Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina J Cardiovasc Pharmacol Ther 16 2011 168 172
18. Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction http://clinicaltrials.gov/ct2/show/NCT00574756 Accessed October 23, 2011
19. C. Jacobshagen, L. Belardinelli, G. Hasenfuss, L.S. Maier Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study Clin Cardiol 34 2011 426 432
20. M.M. Henneman, J. Chen, C. Ypenburg, P. Dibbets, G.B. Bleeker, E. Boersma, M.P. Stokkel, E.E. van der Wall, E.V. Garcia, J.J. Bax Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony J Am Coll Cardiol 49 2007 1708 1714 (Pubitemid 46589921)
21. M.J. Boogers, J. Chen, C.E. Veltman, R.J. van Bommel, E.A. Mooyaart, I. Al Younis, B. van der Hiel, P. Dibbets, E.E. van der Wall, M.J. Schalij, E.V. Garcia, J.J. Bax, V. Delgado Left ventricular diastolic dyssynchrony assessed with phase analysis of gated myocardial perfusion SPECT: a comparison with tissue Doppler imaging Eur J Nucl Med Mol Imaging 38 2011 2031 2039